ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| L Antineoplastic and immunomodulating agents |
|---|
| L01 Antineoplastic agents |
| L02 Endocrine therapy |
| L03 Immunostimulants |
| L04 Immunosuppressants |
|
|
|
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System
| |
|---|---|
|
gastrointestinal tract / metabolism (A) |
|
|
blood and blood forming organs (B) |
|
|
cardiovascular system (C) |
|
| skin (D) | |
|
genitourinary system (G) |
|
|
endocrine system (H) |
|
|
infections and infestations (J, P, QI) |
|
|
malignant disease (L01–L02) |
|
|
immune disease (L03–L04) |
|
|
muscles, bones, and joints (M) |
|
|
brain and nervous system (N) |
|
|
respiratory system (R) |
|
| sensory organs (S) | |
| other ATC (V) | |
